Polysialic interferon-alpha-2b : InferoXen®
InferoXen® is a proprietary polysialylated interferon alpha-2b new product candidate from Lipoxen, which offers potential for use in hepatitis C.
Interferon is a protein which occurs naturally in the body in very small amounts and which exists in 3 types (alpha, beta and gamma). Interferon alpha is produced by the body in response to certain viral infections. It can be administered as a protein drug to boost the body’s immune system and is used as a treatment for hepatitis C and other diseases.
What are the potential advantages of InferoXen®?
Preclinical proof-of-concept studies have demonstrated that InferoXen® has the potential to offer:
- A longer blood circulation time than generic interferon alpha
- Reduced toxicity compared to other polymer-modified forms of interferon alpha due to the use of biodegradable polysialic acid